Atypical teratoid rhabdoid tumor future or investigational therapies

Atypical teratoid rhabdoid tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atypical Teratoid Rhabdoid Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Atypical teratoid rhabdoid tumor future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atypical teratoid rhabdoid tumor future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atypical teratoid rhabdoid tumor future or investigational therapies
CDC on Atypical teratoid rhabdoid tumor future or investigational therapies
Atypical teratoid rhabdoid tumor future or investigational therapies in the news
Blogs on Atypical teratoid rhabdoid tumor future or investigational therapies
Directions to Hospitals Treating Atypical teratoid rhabdoid tumor
Risk calculators and risk factors for Atypical teratoid rhabdoid tumor future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Future or Investigational Therapies

Current research is focusing on using chemotherapy protocols that are effective against rhabdomyosarcoma in combination with surgery and radiation therapy.